Back
Kymera Therapeutics Vs. Pro-Dex Industry Stock Comparison
Buy
62
KYMR
Kymera Therapeutics
Last Price:
47.23
Seasonality Move:
64.33%
Buy
76
PDEX
Pro-Dex
Last Price:
41.47
Seasonality Move:
5.59%
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $46.47. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
76
Pro-Dex (PDEX)
is a Buy
Is Pro-Dex a Buy, Sell or Hold?
- The current Pro-Dex [PDEX] share price is $36.94. The Score for PDEX is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
- PDEX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.47
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 48.42 | Sell |
| Chaikin Money Flow: | 15405 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.04 - 48.38) | Buy |
| Bollinger Bands (100): | (36.99 - 49.05) | Buy |
PDEX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.41 | Buy |
| Relative Strength Index (14 RSI): | 76.65 | Buy |
| Chaikin Money Flow: | -283498 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.46 - 31.46) | Buy |
| Bollinger Bands (100): | (18.4 - 27.76) | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.92 | Sell |
| 20-day SMA: | 46.22 | Buy |
| 50-day SMA: | 47.02 | Sell |
| 200-day SMA: | 39.75 | Buy |
| 8-day EMA: | 47.31 | Sell |
| 20-day EMA: | 47.04 | Sell |
| 50-day EMA: | 46.08 | Buy |
| 200-day EMA: | 39.46 | Buy |
PDEX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.46 | Buy |
| 20-day SMA: | 29.31 | Buy |
| 50-day SMA: | 27.11 | Buy |
| 200-day SMA: | 20.91 | Buy |
| 8-day EMA: | 31.34 | Buy |
| 20-day EMA: | 29.7 | Buy |
| 50-day EMA: | 27.24 | Buy |
| 200-day EMA: | 22.08 | Buy |
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.47 per share.
Pro-Dex Earnings Growth & PDEX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.72 per share, and an increase next year of $0.92 per share.
Kymera Therapeutics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pro-Dex Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||